Citius Oncology, Inc. CTOR Increase (Decrease) in Prepaid Expense
Increase (Decrease) in Prepaid Expense at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidExpense.
The official record: Citius Oncology, Inc.’s 10-Q, filed February 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s increase (decrease) in prepaid expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s increase (decrease) in prepaid expense?
- Citius Oncology, Inc. (CTOR) reported increase (decrease) in prepaid expense of $1.83M in Q4 2025.
- What does increase (decrease) in prepaid expense mean?
- Represents the net change in payments made in advance for goods or services that will be consumed in future periods. An increase indicates cash outflow for future benefits, while a decrease reflects the recognition of these expenses in the current period.